8:00 - 19:00

Working hours MON. - FRI.

 

News

Sterling stabilises; speculators cut back on sterling longs By Reuters

LONDON (Reuters) - Currency market jitters had limited impact on the pound on Monday, which was little changed against the dollar and euro, and positioning data showed speculators reduced their sterling longs but remained bullish. Turkey's surprise decision to fire its central bank governor triggered a plunge in the lira, and commodity currencies including the Australian dollar weakened while the safe-haven yen...

Continue reading

Energy, travel stocks drag UK shares lower; AstraZeneca rises By Reuters

By Shivani Kumaresan (Reuters) -London's FTSE 100 inched lower on Monday, dragged down by energy stocks as oil prices slipped over fears of slowing fuel demand, while a warning from a minister that Britons should wait before booking international travel weighed on travel stocks. The commodity-heavy FTSE 100 index slipped 0.3%, with oil heavyweights BP (LON:BP) and Royal Dutch Shell...

Continue reading

Turkish lira plunges to near record lows on cenbank chief’s sacking By Reuters

By Jonathan Spicer and Ezgi Erkoyun ISTANBUL (Reuters) - Turkey's lira slid 15% to a near all-time low on Monday after President Tayyip Erdogan's shock weekend ousting of a hawkish central bank governor sparked fears of a reversal of recent rate hikes, before clawing back some overnight losses. The appointment of Sahap Kavcioglu, a former banker and ruling party lawmaker, in...

Continue reading

Barclays sticks to Turkey interest rate forecast for 19% until October By Reuters

LONDON (Reuters) - Barclays (LON:BARC) said on Monday it expected Turkey's central bank to keep interest rates stable at 19% until October and then cut 350 basis points to 15.5% in the last quarter following Friday's ouster of central bank chief Naci Agbal. "It is possible to say that (new central bank governor Sahap Kavcioglu) is not an advocate of...

Continue reading

AstraZeneca vaccine 79% effective in U.S. trial, panel finds no higher risk of clots By Reuters

FRANKFURT/LONDON (Reuters) - The COVID-19 vaccine developed by Oxford University and AstraZeneca (NASDAQ:AZN) was 79% effective in preventing symptomatic illness a large trial in the United States, Chile and Peru, the company said on Monday, paving the way for it to apply for U.S. approval. The vaccine was 100% effective against severe or...

Continue reading

Google payments chief quits after 15 years at company By Reuters

(Reuters) - Senior Google (NASDAQ:GOOGL) executive Caesar Sengupta, head of the tech giant's payment initiatives, said on Monday he was leaving the company next month, after 15 years. "I remain very positive about Google's future but it's time for me to see if I can ride without training wheels," Sengupta, vice president and general manager of payments and the 'Next Billion Users'...

Continue reading
en_GBEnglish